Utilizing Augmented Intelligence to Drive Optimal Decisions Throughout the Specialty and Rare Disease Product Lifecycle
By: Dan Fisher, Principal, IPM.ai
Life sciences and healthcare companies that set out to pioneer...
By: Dan Fisher, Principal, IPM.ai
Life sciences and healthcare companies that set out to pioneer...
By: Dan Fisher, Principal, IPM.ai
Conventional clinical study recruitment methods for rare diseases...
By: Dan Fisher, Principal, IPM.ai
Allison Rhee of MM&M reports on IPM.ai's answer to patient...
By: Dan Fisher, Principal, IPM.ai
Though it’s not often discussed, the most difficult aspect of...
Our own Julie Gubitosa and Graham Jones accompanied by Keith R. McCrae, MD of the Cleveland Clinic...
High Noise Healthcare Data Environments Are a Prime Candidate for Advanced Technologies